Final Table Action
Even though Shakerchi came in as the shortest stack, he managed to grab two pay jumps as Volkmann and Loeliger both busted before him. Loeliger was left short when he doubled Salas up who then took out Volkmann with pocket aces. Loeliger then lost the remainder of his stack to Malinowski. Shakerchi managed to double up through Malinowski but then gave them all back to him when he ran his pocket kings into the ace-ten of his opponent. The ace on the turn meant that Shakerchi s hopes of a sixth SCOOP title were over.
Vogelsang was then shot down by Muehloecker as he held pocket sevens but Muehloecker had turned trips which held on the river. The chip lead went back and forth for a while between Salas and Rudolph while Day 1 chip leader Van Fleet was not doing too well. In the end, he got all his chips in on the turn with the open-ended straight draw but Muehloecker s top pair became trips on the river to send Van Fleet to the rail.
Damian pampa27 Salas Wins the 2021 PokerStars SCOOP-72-H: $10,300 NLHE [8-Max] for $263,023 pokernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pokernews.com Daily Mail and Mail on Sunday newspapers.
Message :
Required fields
HOUSTON, April 19, 2021 (GLOBE NEWSWIRE) Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that all three submitted abstracts detailing research involving seclidemstat were accepted for poster presentations, with one abstract also selected for a poster discussion session, at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. ASCO will be held virtually from June 4-8, 2021.
“We are very pleased to report that research involving seclidemstat will be the subject of three poster presentations at the 2021 ASCO Annual Meeting,” stated David Arthur, President and CEO of Salarius Pharmaceuticals. “As previously noted, the full findings from the dose escalation-stage of the Phase 1/2 trial of seclidemstat in patients with relapsed and refractory Ewing sarcoma, including details
CNN correspondent Rene Marsh says son, Blake, 2, has died from brain cancer
In an emotional Instagram post, Marsh writes she s dedicated to fighting pediatric cancer for the rest of my life.
Rene Marsh says her son,
Blake, 2, has passed away from brain cancer.
Marsh has been incredibly vocal about her son’s cancer diagnosis. Last year, she wrote an opinion piece for CNN urging people to wear masks, as it could potentially save the life of her son, who was undergoing chemotherapy at the time. “Living through a pandemic,” she shared, “as a mom of a child with a cancer diagnosis, is terrifying.”